生物制药公司Travere Therapeutics (TVTX) 今日盘中股价大幅上涨5.99%,表现强劲。
消息面上,根据路透报道,华尔街券商Leerink Partners将Travere Therapeutics的目标股价从50美元上调至55美元。分析师上调目标价通常被视为对公司未来前景的积极看法,这提振了市场信心,从而推动了股价上涨。
生物制药公司Travere Therapeutics (TVTX) 今日盘中股价大幅上涨5.99%,表现强劲。
消息面上,根据路透报道,华尔街券商Leerink Partners将Travere Therapeutics的目标股价从50美元上调至55美元。分析师上调目标价通常被视为对公司未来前景的积极看法,这提振了市场信心,从而推动了股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.